EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Pharmacodynamic and Clinical Effects of Ginkgo Biloba Extract EGb 761 and Its Phytochemical Components in Alzheimer’s Disease

Xavier Morató, Juan Pablo Tartari, Vanesa Pytel, Mercè Boada

Journal of Alzheimer's Disease · 2024

DOI: 10.3233/jad-231372 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Alzheimer's Disease, 2024. Verfasst von Xavier Morató und 3 weiteren Autor:innen. Beteiligte Einrichtung: Ace Alzheimer Center Barcelona-Universitat Internacional de Catalunya, Barcelona, Spain. Hauptthemen laut MEDLINE: Ginkgo biloba, Plant Extracts, Alzheimer Disease. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 87 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Extracts made from plants are complex mixtures of substances with varying compositions depending on the plant material and method of manufacture. This complexity makes it difficult for scientists and clinicians to interpret findings from pharmacological and clinical research. We performed a narrative review summarizing information on ginkgo biloba leaf extract, its composition, pharmacological data and clinical evidence supporting its administration for the treatment of Alzheimer’s disease (AD). Medicinal products containing ginkgo biloba leaf extract which are manufactured in compliance with the requirements of the European Pharmacopoeia are approved as medicinal products for the treatment of dementia and related conditions by drug regulatory agencies in Europe, Asia and South America. As multicomponent mixtures, they may affect various targets in the pathogenesis of AD, the most common form of dementia. Pharmacodynamic studies demonstrate the effects of EGb 761 and individual constituents on various pathophysiological features of experimentally induced cognitive impairment and neurodegeneration that could contribute to its clinical efficacy. The safety and efficacy in the treatment of AD and cognitive decline has been studied in randomized, placebo-controlled clinical trials. Most of the studies that investigate the effects of ginkgo biloba extract (GbE) used the special extract EGb 761, which makes it the best-researched plant preparation worldwide. It is therefore the only herbal alternative to standard-of-care anti-dementia drugs. However, the mechanism of action has not been fully elucidated yet, and the clinical studies in AD show heterogeneity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ginkgo bilobaPlant ExtractsAlzheimer DiseaseHumansAnimalsPhytotherapyGinkgo Extract

Stichwörter der Autor:innen

Alzheimer’s disease clinical studiesEGb 761Ginkgo biloba L. extractpharmacological studies

Substanzen

Plant ExtractsGinkgo biloba extractGinkgo Extract

Autor:innen und Institutionen

  • Ace Alzheimer Center Barcelona-Universitat Internacional de Catalunya, Barcelona, Spain.
  • Networking Research Center on Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain.

Zitieren

APA

Morató, X., Tartari, J. P., Pytel, V., & Boada, M. (2024). Pharmacodynamic and Clinical Effects of Ginkgo Biloba Extract EGb 761 and Its Phytochemical Components in Alzheimer’s Disease. Journal of Alzheimer's Disease. https://doi.org/10.3233/jad-231372

Vancouver

Morató X, Tartari JP, Pytel V, Boada M. Pharmacodynamic and Clinical Effects of Ginkgo Biloba Extract EGb 761 and Its Phytochemical Components in Alzheimer’s Disease. Journal of Alzheimer's Disease. 2024. doi:10.3233/jad-231372

BibTeX
@article{Morat2024,
  author = {Morató, Xavier and Tartari, Juan Pablo and Pytel, Vanesa and Boada, Mercè},
  title = {Pharmacodynamic and Clinical Effects of Ginkgo Biloba Extract EGb 761 and Its Phytochemical Components in Alzheimer’s Disease},
  journal = {Journal of Alzheimer's Disease},
  year = {2024},
  doi = {10.3233/jad-231372}
}
Kostenlos starten →